Clinical Trial Update: Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial comparing oral ribavirin and nitazoxamide versus placebo in COVID-19/SARS-CoV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov Infection

Drugs mentioned

• Ribavirin (ribavirin)
• nitazoxamide (nitazoxamide)

Snippet

Sponsor: University of Witwatersrand, South Africa | Conditions: Covid19, SARS-CoV Infection | Phase 2 | Status: COMPLETED